These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 11207269

  • 1. Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase.
    Barel M, Le Romancer M, Frade R.
    J Immunol; 2001 Mar 01; 166(5):3167-73. PubMed ID: 11207269
    [Abstract] [Full Text] [Related]

  • 2. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
    Bouillie S, Barel M, Frade R.
    J Immunol; 1999 Jan 01; 162(1):136-43. PubMed ID: 9886379
    [Abstract] [Full Text] [Related]

  • 3. Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav.
    Lottin-Divoux S, Jean D, Le Romancer M, Frade R.
    Cell Signal; 2006 Aug 01; 18(8):1219-25. PubMed ID: 16289966
    [Abstract] [Full Text] [Related]

  • 4. Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt-GSK3 activities upstream and downstream to PI 3-kinase, respectively.
    Barel M, Balbo M, Le Romancer M, Frade R.
    Eur J Immunol; 2003 Sep 01; 33(9):2557-66. PubMed ID: 12938232
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. gp140, the EBV/C3d receptor (CR2) of human B lymphocytes, is involved in cell-free phosphorylation of p120, a nuclear ribonucleoprotein.
    Delcayre AX, Fiandino A, Barel M, Frade R.
    Eur J Immunol; 1987 Dec 01; 17(12):1827-33. PubMed ID: 2446881
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
    Buhl AM, Cambier JC.
    J Immunol; 1999 Apr 15; 162(8):4438-46. PubMed ID: 10201980
    [Abstract] [Full Text] [Related]

  • 12. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M, Poe JC, Jansen PJ, Sato S, Tedder TF.
    J Immunol; 1999 Jun 15; 162(12):7088-94. PubMed ID: 10358152
    [Abstract] [Full Text] [Related]

  • 13. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
    Lee Y, Haas KM, Gor DO, Ding X, Karp DR, Greenspan NS, Poe JC, Tedder TF.
    J Immunol; 2005 Dec 15; 175(12):8011-23. PubMed ID: 16339538
    [Abstract] [Full Text] [Related]

  • 14. The CR2/CD19 complex on human B cells contains the src-family kinase Lyn.
    van Noesel CJ, Lankester AC, van Schijndel GM, van Lier RA.
    Int Immunol; 1993 Jul 15; 5(7):699-705. PubMed ID: 7690241
    [Abstract] [Full Text] [Related]

  • 15. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
    Ishiura N, Nakashima H, Watanabe R, Kuwano Y, Adachi T, Takahashi Y, Tsubata T, Okochi H, Tamaki K, Tedder TF, Fujimoto M.
    Eur J Immunol; 2010 Apr 15; 40(4):1192-204. PubMed ID: 20101619
    [Abstract] [Full Text] [Related]

  • 16. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein.
    Faris M, Gaskin F, Parsons JT, Fu SM.
    J Exp Med; 1994 Jun 01; 179(6):1923-31. PubMed ID: 7515102
    [Abstract] [Full Text] [Related]

  • 17. Integration of activatory and inhibitory signals in human B-cells.
    Sármay G, Koncz G, Gergely J.
    Immunol Lett; 1996 Dec 01; 54(2-3):93-100. PubMed ID: 9052860
    [Abstract] [Full Text] [Related]

  • 18. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
    Carter RH, Tuveson DA, Park DJ, Rhee SG, Fearon DT.
    J Immunol; 1991 Dec 01; 147(11):3663-71. PubMed ID: 1719083
    [Abstract] [Full Text] [Related]

  • 19. gp 140, the C3d/EBV receptor (CR2), is phosphorylated upon in vitro activation of human peripheral B lymphocytes.
    Barel M, Vazquez A, Charriaut C, Aufredou MT, Galanaud P, Frade R.
    FEBS Lett; 1986 Mar 03; 197(1-2):353-6. PubMed ID: 2936622
    [Abstract] [Full Text] [Related]

  • 20. Purification and identification of tyrosine-phosphorylated proteins from B lymphocytes stimulated through the antigen receptor.
    Gold MR, Yungwirth T, Sutherland CL, Ingham RJ, Vianzon D, Chiu R, van Oostveen I, Morrison HD, Aebersold R.
    Electrophoresis; 1994 Mar 03; 15(3-4):441-53. PubMed ID: 7519980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.